Reducing Post-Letermovir CMV Infection: Efficacy of an Immune-Reconstitution-Based Scoring System to Guide Prophylaxis Duration
Clinical trial NCT07443501 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07443501
- Sponsor
- Institute of Hematology & Blood Diseases Hospital, China
- Status
- NOT_YET_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2026-03-14
- Primary completion
- 2027-12-14
- Enrollment
- 1114
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.